Exact Sciences pockets $245M in stock sale & more — 6 GI company key notes

Here are six updates on GI companies from the past week.

Advertisement

Exact Sciences sold an additional 7 million shares for a gross proceeds of $245 million.

Valeant Pharmaceuticals added billionaire hedge fund manager John Paulson to its board of directors.

GI Dynamics added Francesco Rubino, MD, and Philip Schauer, MD, to its scientific advisory board.

Q BioMed finalized an agreement with The Oklahoma Medical Research Foundation and the Rajiv Gandhi Centre for Biotechnology to develop a novel liver cancer chemotherapy.

S&S Plastics and StarMed collaborated on an endoscopy bottle top to keep camera lenses clean during procedures.

The Taiwan Government Industrial Development Bureau awarded CellMax Life a $760,846 grant for its cancer detection platform.

More articles on gastroenterology:
GI center to know: Texas Digestive Disease Consultants
GI leader to know: Dr. Ray Keate of Richmond Gastroenterology Associates
3 new GI-driven ASCs & outpatient facilities — May 2017

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.